JP Morgan Private Wealth Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-17,392	Closed	-$938K	–	1424
2017 Q4	$938K	Buy	17,392 +9,340	+116%	+$511K	0.01%	673
2017 Q3	$459K	Sell	8,052 -397	-5%	-$23.3K	﹤0.01%	881
2017 Q2	$508K	Sell	8,449 -3,541	-30%	-$202K	﹤0.01%	835
2017 Q1	$653K	Buy	+11,990	New	+$591K	0.01%	763

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

JP Morgan Private Wealth Advisors's BIVV Position: Q1 2018 in Review

JP Morgan Private Wealth Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 17,392 shares — an estimated $938K sold.

JP Morgan Private Wealth Advisors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $938K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

JP Morgan Private Wealth Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 17,392 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $938K.
JP Morgan Private Wealth Advisors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
JP Morgan Private Wealth Advisors's Bioverativ Inc. Common Stock position peaked at $938K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2018, filed 10 May 2018.